soul trial semaglutide (NEJM 2025): Oral led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine Post hoc analysis of SUSTAIN
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13











![PDF] Sublingual vitamin B12 compared to intramuscular injection in patients with type 2 diabetes treated with metformin: a randomised trial](https://figures.semanticscholar.org/09492d7c4a2f76a1fddc09d55b909d3b4f259caf/5-Table1-1.png)














